Research map: Cytokine Changes With Effective Drug Therapy for Juvenile Myasthenia Gravis

Back to the article

Papers in this map

  1. Sangerbox: A comprehensive, interaction‐friendly clinical bioinformatics analysis platform · Weitao Shen · 2022 · 1239 citations · Cited by this paper
  2. Dynamics of Circulating Follicular Helper and Regulatory T‐Cell Memory Induced by mRNA, Inactivated, and Live‐Attenuated Vaccines · 2026 · Related
  3. International consensus guidance for management of myasthenia gravis · Donald B. Sanders · 2016 · 1211 citations · Cited by this paper
  4. P2 Receptors as Therapeutic Targets in Allergic Rhinitis: Insights From the Use of Natural Products and Preclinical Studies · 2026 · Related
  5. Chemokines and the immune response to cancer · Aleksandra J. Ozga · 2021 · 863 citations · Cited by this paper
  6. Metal Ions Within the Neuro–Immune–Tumor Axis · 2026 · Related
  7. International Consensus Guidance for Management of Myasthenia Gravis · Pushpa Narayanaswami · 2020 · 801 citations · Cited by this paper
  8. T Follicular Helper Cell Immune Signatures Associated With Disease Severity in Severe Fever With Thrombocytopenia Syndrome · 2026 · Related
  9. Myasthenia gravis: recommendations for clinical research standards · Alfred Jaretzki · 2000 · 648 citations · Cited by this paper
  10. MicroRNA‐382 Is Involved in Acute Kidney Injury via Regulating STAT1 Signaling · 2026 · Related
  11. Clinical evaluation and management of myasthenia gravis · John Keesey · 2004 · 284 citations · Cited by this paper
  12. A Bead‐Based Screening Platform for Identifying Monoclonal Antibodies That Disrupt PD‐1/PD‐L1 Interactions · 2026 · Related
  13. Characteristics of myasthenia gravis according to onset-age: Japanese nationwide survey · Hiroyuki Murai · 2011 · 175 citations · Cited by this paper
  14. The Role of BMAL1 in Regulating Circadian Rhythms During Airway Remodeling in Asthma · 2026 · Related
  15. Genetic basis of myasthenia gravis – A comprehensive review · Nili Avidan · 2013 · 139 citations · Cited by this paper
  16. Anti‐MAG Polyneuropathy: Characterization of the Monoclonal Gammopathy and Clonal B‐Cell Population · 2026 · Related
  17. CD40–CD40L in Neurological Disease · Heather D. Ots · 2022 · 64 citations · Cited by this paper
  18. Peripheral Blood Neutrophils and Monocytes Predict Disease Progression in Stage III Melanoma Patients Treated With Anti Programmed Cell Death Protein‐1 (PD‐1) Inhibitors · 2026 · Related
  19. Myasthenia gravis exacerbation and myasthenic crisis associated with COVID-19: case series and literature review · Cleonísio Leite Rodrigues · 2022 · 45 citations · Cited by this paper
  20. CAR‐Cell Therapy for Autoimmune Diseases: From the Laboratory to Clinical Practice · 2026 · Related
  21. Ablation of IL-17 expression moderates experimental autoimmune myasthenia gravis disease severity · Gabriela Aguilo-Seara · 2017 · 38 citations · Cited by this paper
  22. The role of innate immunity in myasthenia gravis · Rui Zhao · 2021 · 27 citations · Cited by this paper
  23. Construction of an miRNA-regulated drug-pathway network reveals drug repurposing candidates for myasthenia gravis · Yuze Cao · 2017 · 20 citations · Cited by this paper
  24. Chinese herbal medicine for myasthenia gravis: A systematic review and meta-analysis of randomized clinical trials · Sijia Zhu · 2021 · 20 citations · Cited by this paper
  25. Blood Transcriptome Profiling in Myasthenia Gravis Patients to Assess Disease Activity: A Pilot RNA-seq Study · Kee Hong Park · 2016 · 17 citations · Cited by this paper
  26. Prognostic biomarker MCP-4 triggers epithelial-mesenchymal transition via the p38 MAPK pathway in ovarian cancer · Siting Li · 2022 · 17 citations · Cited by this paper
  27. Traditional Chinese medicine improves myasthenia gravis by regulating the symbiotic homeostasis of the intestinal microbiota and host · Mingli Zhao · 2023 · 11 citations · Cited by this paper
  28. Hypothalamic kisspeptin alleviates myasthenia gravis by regulating Th1/Th17/Treg balance through Inhibition of NF-κB signaling pathway · Dan Lu · 2025 · 11 citations · Cited by this paper
  29. Myasthenia gravis: The pharmacological basis of traditional Chinese medicine for its clinical application · Shen Xiaoyue · 2021 · 10 citations · Cited by this paper
  30. Driving IL ‐17+ γδ T ‐cell migration in allergic reactions: A new “inflammatory” role for the “homeostatic” chemokine CCL 25 · Bruno Silva‐Santos · 2012 · 7 citations · Cited by this paper
  31. Inflammatory imbalance and activation deficits in T cells of myasthenia gravis patients revealed by proteomic profiling · Amol Keshavasa Bhandage · 2025 · 6 citations · Cited by this paper
  32. Effect of Jianpiyiqi granule on ocular myasthenia gravis in children prepared with a formula from Traditional Chinese Medicine · Guoyan Qi · 2017 · 5 citations · Cited by this paper
  33. Alterations in plasma cytokine profiles in generalized myasthenia gravis following different immunotherapeutic regimens · Zhuangzhuang Ren · 2025 · 5 citations · Cited by this paper
  34. Circulating inflammatory cytokines and the risk of myasthenia gravis: a bidirectional Mendelian randomization study · Boyang Su · 2025 · 4 citations · Cited by this paper
  35. Toll-like receptors and their role in the pathogenesis of myasthenia gravis: a comprehensive review · Xiaoxiao Zheng · 2025 · 2 citations · Cited by this paper

Source: OpenAlex (CC0)